Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Outcome of CT-guided Radioactive Iodine-125 Seeds Implantation for Inoperable Early Stage Non-small Cell Lung Cancer

NCT03916367 is registered in ClinicalTrials.gov with Peking University Third Hospital as lead sponsor.

NCT NCT03916367
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03916367 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Outcome of CT-guided Radioactive Iodine-125 Seeds Implantation for Inoperable Early Stage Non-small Cell Lung Cancer
Lead sponsor
Peking University Third Hospital
Phase
Observational
Overall status
Completed
Start date
December 15, 2010
Completion date
February 15, 2019
Enrollment
39 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

early stage non-small cell lung cancer